コンテンツへスキップ
Merck
  • Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results.

Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results.

Infection (1990-01-01)
H Thoumsin, M Aghayan, R Lambotte
要旨

Pregnancy induces anatomical and physiological changes in the urinary tract. In this condition a bacteriuria, even asymptomatic, may lead more frequently to pyelonephritis. Asymptomatic bacteriuria in pregnant women has therefore got to be treated. According to recent studies, long course antibiotherapy did not prove to be more effective than a single-dose one in the case of non-complicated bacteriuria. Moreover, the maternal and foetal toxicity should be reduced in the latter regimen. In this paper we present the preliminary results of our study comparing a single-dose treatment by fosfomycin trometamol (3 g) and nitrofurantoin (200 mg per day during a week).

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ニトロフラントイン, 98.0-102.0% (EP, UV)
USP
ニトロフラントイン, United States Pharmacopeia (USP) Reference Standard
Supelco
ニトロフラントイン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ニトロフラントイン, VETRANAL®, analytical standard